Merck & Co »

Kymera Therapeutics shares owned by Merck & Co

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Merck & Co from 13F filings

Historical chart of Merck & Co investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Merck & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Merck & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $44M 772k 56.60
2025-06-30 $34M 772k 43.64